Nektar Therapeutics Increase (Decrease) in Accounts Receivable
Nektar Therapeutics (NKTR) reported Increase (Decrease) in Accounts Receivable of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-03-13
- Nektar Therapeutics increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Nektar Therapeutics increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Nektar Therapeutics increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $0.00.
- Nektar Therapeutics increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Nektar Therapeutics increase (decrease) in accounts receivable for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Nektar Therapeutics increase (decrease) in accounts receivable for fiscal 2024 was $3.04M.
- Nektar Therapeutics increase (decrease) in accounts receivable for fiscal 2023 was -$4.78M.
- Nektar Therapeutics increase (decrease) in accounts receivable for fiscal 2022 was -$16.51M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-13 | $0.00 derived: sum of 3 quarters · filed 2026-03-13 | $0.00 10-K · filed 2026-03-13 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | $2.20M derived: sum of 4 quarters · filed 2026-03-13 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $2.20M derived: sum of 3 quarters · filed 2026-03-13 | $3.05M derived: sum of 4 quarters · filed 2026-03-13 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | $2.20M derived: sum of 2 quarters · filed 2026-03-13 | $3.05M derived: sum of 3 quarters · filed 2026-03-13 | $633.00K derived: sum of 4 quarters · filed 2026-03-13 | |
| 2024-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $3.05M derived: sum of 2 quarters · filed 2026-03-13 | $633.00K derived: sum of 3 quarters · filed 2026-03-13 | $3.04M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $850.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$1.57M derived: sum of 2 quarters · filed 2025-11-07 | $841.00K 10-Q · filed 2025-11-07 | -$158.00K derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$9.00K 10-Q · filed 2025-08-08 | -$1.01M derived: sum of 3 quarters · filed 2025-08-08 | -$139.00K derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $2.41M 10-Q · filed 2025-05-09 | $1.41M derived: sum of 2 quarters · filed 2025-05-09 | $2.28M derived: sum of 3 quarters · filed 2025-05-09 | $622.00K derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | -$999.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | -$130.00K derived: sum of 2 quarters · filed 2025-03-14 | -$1.79M derived: sum of 3 quarters · filed 2025-03-14 | -$4.78M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $869.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$791.00K derived: sum of 2 quarters · filed 2024-11-08 | -$3.78M 10-Q · filed 2024-11-08 | -$9.33M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$4.65M 10-Q · filed 2024-08-09 | -$10.20M derived: sum of 3 quarters · filed 2024-08-09 | -$8.67M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | -$2.99M 10-Q · filed 2024-05-10 | -$8.54M derived: sum of 2 quarters · filed 2024-05-10 | -$7.01M derived: sum of 3 quarters · filed 2024-05-10 | -$27.23M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | -$5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$4.03M derived: sum of 2 quarters · filed 2024-03-05 | -$24.24M derived: sum of 3 quarters · filed 2024-03-05 | -$16.51M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$18.69M derived: sum of 2 quarters · filed 2023-11-08 | -$10.96M 10-Q · filed 2023-11-08 | -$13.46M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | -$20.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$12.49M 10-Q · filed 2023-08-09 | -$14.99M derived: sum of 3 quarters · filed 2024-03-05 | -$14.87M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | $7.73M 10-Q · filed 2023-05-10 | $5.23M derived: sum of 2 quarters · filed 2024-03-05 | $5.35M derived: sum of 3 quarters · filed 2024-03-05 | $5.06M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$2.38M derived: sum of 2 quarters · filed 2024-03-05 | -$2.66M derived: sum of 3 quarters · filed 2024-03-05 | -$12.40M 10-K · filed 2024-03-05 | |
| 2021-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$162.00K derived: sum of 2 quarters · filed 2022-11-04 | -$9.89M 10-Q · filed 2022-11-04 | -$17.93M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | -$285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$10.02M 10-Q · filed 2022-08-05 | -$18.05M derived: sum of 3 quarters · filed 2023-02-28 | -$22.37M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | -$9.73M 10-Q · filed 2022-05-06 | -$17.77M derived: sum of 2 quarters · filed 2023-02-28 | -$22.09M derived: sum of 3 quarters · filed 2023-02-28 | -$16.88M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$8.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$12.36M derived: sum of 2 quarters · filed 2023-02-28 | -$7.14M derived: sum of 3 quarters · filed 2023-02-28 | -$1.91M 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$4.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $894.00K derived: sum of 2 quarters · filed 2021-11-05 | $6.12M 10-Q · filed 2021-11-05 | $1.72M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $10.44M 10-Q · filed 2021-08-06 | $6.04M derived: sum of 3 quarters · filed 2022-03-01 | $9.95M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $5.23M 10-Q · filed 2021-05-07 | $826.00K derived: sum of 2 quarters · filed 2022-03-01 | $4.73M derived: sum of 3 quarters · filed 2022-03-01 | -$863.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$497.00K derived: sum of 2 quarters · filed 2022-03-01 | -$6.09M derived: sum of 3 quarters · filed 2022-03-01 | -$6.41M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $3.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$1.69M derived: sum of 2 quarters · filed 2020-11-06 | -$2.01M 10-Q · filed 2020-11-06 | $7.32M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | -$5.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$5.91M 10-Q · filed 2020-08-07 | $3.41M derived: sum of 3 quarters · filed 2021-02-26 | $34.00K derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | -$319.00K 10-Q · filed 2020-05-08 | $9.01M derived: sum of 2 quarters · filed 2021-02-26 | $5.63M derived: sum of 3 quarters · filed 2021-02-26 | $25.34M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $9.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $5.95M derived: sum of 2 quarters · filed 2021-02-26 | $25.66M derived: sum of 3 quarters · filed 2021-02-26 | $25.50M 10-K · filed 2021-02-26 | |
| 2018-09-30 | -$3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $16.33M derived: sum of 2 quarters · filed 2019-11-07 | $16.18M 10-Q · filed 2019-11-07 | $17.88M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2018-06-30 | $19.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $19.56M 10-Q · filed 2019-08-09 | $21.26M derived: sum of 3 quarters · filed 2020-02-28 | $20.46M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2018-03-31 | -$151.00K 10-Q · filed 2019-05-09 | $1.55M derived: sum of 2 quarters · filed 2020-02-28 | $749.00K derived: sum of 3 quarters · filed 2020-02-28 | $3.30M derived: sum of 4 quarters · filed 2020-02-28 | |
| 2017-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $900.00K derived: sum of 2 quarters · filed 2020-02-28 | $3.45M derived: sum of 3 quarters · filed 2020-02-28 | -$10.66M 10-K · filed 2020-02-28 | |
| 2017-09-30 | -$800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.75M derived: sum of 2 quarters · filed 2018-11-08 | -$12.36M 10-Q · filed 2018-11-08 | -$10.94M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | $2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$11.56M 10-Q · filed 2018-08-09 | -$10.13M derived: sum of 3 quarters · filed 2019-03-01 | -$23.66M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | -$14.11M 10-Q · filed 2018-05-10 | -$12.68M derived: sum of 2 quarters · filed 2019-03-01 | -$26.21M derived: sum of 3 quarters · filed 2019-03-01 | -$38.11M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$12.10M derived: sum of 2 quarters · filed 2019-03-01 | -$24.00M derived: sum of 3 quarters · filed 2019-03-01 | -$4.27M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$13.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$25.43M derived: sum of 2 quarters · filed 2017-11-08 | -$5.70M 10-Q · filed 2017-11-08 | $11.28M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | -$11.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $7.83M 10-Q · filed 2017-08-09 | $24.81M derived: sum of 3 quarters · filed 2018-03-01 | $24.10M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-03-31 | $19.73M 10-Q · filed 2017-05-10 | $36.71M derived: sum of 2 quarters · filed 2018-03-01 | $36.00M derived: sum of 3 quarters · filed 2018-03-01 | $36.79M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | $16.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $16.27M derived: sum of 2 quarters · filed 2018-03-01 | $17.06M derived: sum of 3 quarters · filed 2018-03-01 | $16.34M 10-K · filed 2018-03-01 | |
| 2015-09-30 | -$714.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $81.00K derived: sum of 2 quarters · filed 2016-11-04 | -$641.00K 10-Q · filed 2016-11-04 | -$43.11M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $795.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $73.00K 10-Q · filed 2016-08-04 | -$42.39M derived: sum of 3 quarters · filed 2017-03-01 | $633.00K derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | -$722.00K 10-Q · filed 2016-05-04 | -$43.19M derived: sum of 2 quarters · filed 2017-03-01 | -$162.00K derived: sum of 3 quarters · filed 2017-03-01 | $1.03M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | -$42.47M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $560.00K derived: sum of 2 quarters · filed 2017-03-01 | $1.75M derived: sum of 3 quarters · filed 2017-03-01 | $1.38M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $43.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $44.22M derived: sum of 2 quarters · filed 2015-11-06 | $43.84M 10-Q · filed 2015-11-06 | $41.52M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $818.00K 10-Q · filed 2015-08-06 | -$1.51M derived: sum of 3 quarters · filed 2016-02-29 | -$2.99M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | -$374.00K 10-Q · filed 2015-05-01 | -$2.70M derived: sum of 2 quarters · filed 2016-02-29 | -$4.19M derived: sum of 3 quarters · filed 2016-02-29 | -$1.79M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$3.81M derived: sum of 2 quarters · filed 2016-02-29 | -$1.42M derived: sum of 3 quarters · filed 2016-02-29 | -$3.58M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $910.00K derived: sum of 2 quarters · filed 2014-11-07 | -$1.25M 10-Q · filed 2014-11-07 | $646.00K derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-06-30 | $2.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $236.00K 10-Q · filed 2014-08-01 | $2.13M derived: sum of 3 quarters · filed 2015-02-26 | -$5.32M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-03-31 | -$2.16M 10-Q · filed 2014-05-08 | -$264.00K derived: sum of 2 quarters · filed 2015-02-26 | -$7.71M derived: sum of 3 quarters · filed 2015-02-26 | -$7.16M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2012-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$5.56M derived: sum of 2 quarters · filed 2015-02-26 | -$5.00M derived: sum of 3 quarters · filed 2015-02-26 | $867.00K 10-K · filed 2015-02-26 | |
| 2012-09-30 | -$7.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$6.89M derived: sum of 2 quarters · filed 2013-11-07 | -$1.03M 10-Q · filed 2013-11-07 | $1.03M 10-Q · filed 2012-11-09 | -$33.38M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $558.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $6.42M 10-Q · filed 2013-08-09 | -$25.93M derived: sum of 3 quarters · filed 2014-02-27 | $2.90M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2012-03-31 | $5.87M 10-Q · filed 2013-05-09 | -$26.49M derived: sum of 2 quarters · filed 2014-02-27 | $2.34M derived: sum of 3 quarters · filed 2014-02-27 | $8.64M derived: sum of 4 quarters · filed 2014-02-27 | |
| 2011-12-31 | -$32.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | -$3.52M derived: sum of 2 quarters · filed 2014-02-27 | $2.78M derived: sum of 3 quarters · filed 2014-02-27 | -$20.16M 10-K · filed 2014-02-27 | |
| 2011-09-30 | $28.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $35.13M derived: sum of 2 quarters · filed 2012-11-09 | $12.19M 10-Q · filed 2012-11-09 | -$12.19M 10-Q · filed 2011-11-04 | $31.74M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $6.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$16.64M 10-Q · filed 2012-08-09 | $2.91M derived: sum of 3 quarters · filed 2013-03-01 | -$986.00K derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-03-31 | -$22.94M 10-Q · filed 2012-05-04 | -$3.39M derived: sum of 2 quarters · filed 2013-03-01 | -$7.29M derived: sum of 3 quarters · filed 2013-03-01 | -$5.55M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2010-12-31 | $19.55M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $15.66M derived: sum of 2 quarters · filed 2013-03-01 | $17.39M derived: sum of 3 quarters · filed 2013-03-01 | $20.30M 10-K · filed 2013-03-01 | |
| 2010-09-30 | -$3.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$2.16M derived: sum of 2 quarters · filed 2011-11-04 | $752.00K 10-Q · filed 2011-11-04 | ||
| 2010-06-30 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $4.64M 10-Q · filed 2011-08-05 | |||
| 2010-03-31 | $2.91M 10-Q · filed 2011-04-29 | ||||
| 2009-12-31 | -$6.03M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |